A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [(18)F]FDG PET-CT studies performed in oncologic patients

PURPOSE: The incidence of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) is high following the administration of the first and second BNT162b2 vaccine doses. The impact of this finding on [(18)F]FDG PET-CT interpretation and its correlation with the induced humoral immunity have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Dan, Hazut Krauthammer, Shir, Wolf, Ido, Even-Sapir, Einat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516623/
https://www.ncbi.nlm.nih.gov/pubmed/34651230
http://dx.doi.org/10.1007/s00259-021-05579-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516623/
https://www.ncbi.nlm.nih.gov/pubmed/34651230
http://dx.doi.org/10.1007/s00259-021-05579-7

Ejemplares similares